Review of vascularised bone tissue-engineering strategies with a focus on co-culture systems

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 2, 2015, Pages 85-105

  Liu, Yuchun ^a,b   Chan, Jerry K Y ^b,c,d   Teoh, Swee Hin ^a  

^a Nanyang Technological University   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Bioreactor; Bone tissue engineering; Co culture; Endothelial; Hypoxia; Mesenchymal stem cell; Scaffold; Vascularization

Indexed keywords

BLOOD VESSELS; BONE; CELL ENGINEERING; ENDOTHELIAL CELLS; GRAFTS; REPAIR; SCAFFOLDS (BIOLOGY); STEM CELLS;

ANGIOGENESIS; BIOREACTOR; BONE FORMATION; BONE TISSUE ENGINEERING; CO-CULTURE SYSTEM; CO-CULTURES; ENDOTHELIAL; HYPOXIA; MESENCHYMAL STEM CELL; VASCULARIZATION;

CELL CULTURE;

COLLAGEN; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; VASCULOTROPIN;

ANGIOGENESIS; BONE GRAFT; BONE MINERALIZATION; BONE REGENERATION; BONE STRUCTURE; BONE TISSUE; COCULTURE; CORTICAL BONE; CULTURE MEDIUM; DISTRACTION OSTEOGENESIS; ENCHONDRAL OSSIFICATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FRACTURE HEALING; HUMAN; INTRAMEMBRANOUS OSSIFICATION; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MICROVASCULATURE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OXYGEN TISSUE LEVEL; PERIOSTEUM; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION; TISSUE ENGINEERING; TISSUE SCAFFOLD; TRABECULAR BONE; VASCULARISED BONE TISSUE ENGINEERING; VASCULARIZATION; ANIMAL; ANOXIA; BIOREACTOR; BONE; BONE DEVELOPMENT; BONE REMODELING; CYTOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATIVE MEDICINE;

ANIMALS; ANOXIA; BIOREACTORS; BONE AND BONES; BONE REMODELING; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; OSTEOGENESIS; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84920941427     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1617     Document Type: Review

References (205)

1. Aguirre A, Planell JA, Engel E. 2010; Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis. Biochem Biophys Res Commun 400(2): 284-291.
2. Ai-Aql ZS, Alagl AS, Graves DT et al. 2008; Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 87(2): 107-118.
3. Aird WC. 2007; Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100(2): 158-173.
4. Asahara T, Murohara T, Sullivan A et al. 1997; Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302): 964-967.
5. Atesok K, Li R, Stewart DJ et al. 2010; Endothelial progenitor cells promote fracture healing in a segmental bone defect model. J Orthop Res 28(8):1007-1014.
6. Bae JH, Song HR, Kim HJ et al. 2011; Discontinuous release of bone morphogenetic protein-2 loaded within interconnected pores of honeycomb-like polycaprolactone scaffold promotes bone healing in a large bone defect of rabbit ulna. Tissue Eng Part A 17(19-20): 2389-2397.
7. BBC. 2012; Printing a human kidney. (citation. available from http://www.bbc.com/future/story/20120621-printing-a-human-kidney.
8. Bensaid W, Oudina K, Viateau V et al. 2005. De novo reconstruction of functional bone by tissue engineering in the metatarsal sheep model. Tissue Eng 11(5-6): 814-824.
9. Bidarra SJ, Barrias CC, Barbosa MA et al. 2011. Phenotypic and proliferative modulation of human mesenchymal stem cells via crosstalk with endothelial cells. Stem Cell Res 7(3): 186-197.
10. Biggs MJ, Richards R, Gadegaard G et al. 2009; The use of nanoscale topography to modulate the dynamics of adhesion formation in primary osteoblasts and ERK/MAPK signalling in STRO-1+ enriched skeletal stem cells. Biomaterials 30(28): 5094-5103.
11. Boilly B, Vercoutter-Edouart AS, Hondermarck H et al. 2000; FGF signals for cell proliferation and migration through different pathways. Cytokine Growth F R 11(4): 295-302.
12. Boraiah S, Paul O, Hawkes D et al. 2009; Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report. Clin Orthop Relat R 467(12): 3257-3262.
13. Breitbart AS, Grande DA, Kessler R et al. 1998; Tissue engineered bone repair of calvarial defects using cultured periosteal cells. Plast Reconstr Surg 101(3): 567-574; discussion 575-566.
14. Bruder SP, Fox BS. 1999; Tissue engineering of bone. Cell based strategies. Clin Orthop Relat Res (367 Suppl): S68-83.
15. Bruder SP, Jaiswal N, Haynesworth SE. 1997; Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64(2): 278-294.
16. Bruder SP, Kraus KH, Goldberg VM et al. 1998a; The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80(7): 985-996.
17. Bruder SP, Kurth AA, Shea M et al. 1998b; Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. Journal of orthopaedic research: official publication of the Orthopaedic Research Society 16(2): 155-162.
18. Bullens PH, Schreuder HW, de Waal Malefijt MC et al. 2010; The presence of periosteum is essential for the healing of large diaphyseal segmental bone defects reconstructed with trabecular metal: a study in the femur of goats. J Biomed Mater Res B Appl Biomater 92(1): 24-31.
19. Campagnoli C, Roberts IA, Kumar S et al. 2001; Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98(8): 2396-2402.
20. Caplan AI, Dennis JE. 2006; Mesenchymal stem cells as trophic mediators. J Cell Biochem 98: 1076-1084.
21. Carmeliet P, Jain RK. 2000; Angiogenesis in cancer and other diseases. Nature 407(6801): 249-257.
22. Carter DR, Beaupré GS. 2001; Skeletal function and form: mechanobiology of skeletal development, aging, and regeneration. Cambridge University Press: Cambridge New York.
23. Carter DR, Beaupre GS, Giori NJ et al. 1998; Mechanobiology of skeletal regeneration. Clin Orthop Relat Res (355 Suppl): S41-55.
24. Colnot C. 2009; Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 24(2): 274-282.
25. Conn PM. 2008; Sourcebook of models for biomedical research. Humana Press: Totowa, N.J.
26. Connolly JG, Tiedeman R, Dehne JR. 1989; Autologous marrow injection for delayed unions of the tibia: a preliminary report. J Orthop Trauma 3: 276-282.
27. Cool S, Jackson R, Pincus P et al. 2002; Fibroblast growth factor receptor 4 (FGFR4) expression in newborn murine calvaria and primary osteoblast cultures. Int J Dev Biol 46(4): 519-523.
28. Cool SM, Nurcombe V. 2005; The osteoblast-heparan sulfate axis: control of the bone cell lineage. Int J Biochem Cell Biol 37(9): 1739-1745.
29. Cool SM, Nurcombe V. 2006; Heparan sulfate regulation of progenitor cell fate. J Cell Biochem 99(4): 1040-1051.
30. Coulon C, Georgiadou M, Roncal C et al. 2010; From vessel sprouting to normalization: role of the prolyl hydroxylase domain protein/hypoxia-inducible factor oxygen-sensing machinery. Arterioscler Thromb Vasc Biol 30(12): 2331-2336.
31. D'Amore PA, Thompson RW. 1987; Mechanisms of angiogenesis. Annu Rev Physiol 49:453-464.
32. De Bari C, Dell'Accio F, Vanlauwe J et al. 2006; Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 54(4): 1209-1221.
33. Deng HW, Liu YZ. 2005; Current topics in bone biology. World Scientific: Hackensack, NJ.
34. Dimmeler S, Zeiher AM. 2009; Cell therapy of acute myocardial infarction: open questions. Cardiology 113(3): 155-160.
35. Dohle E, Fuchs S, Kolbe M et al. 2010; Sonic hedgehog promotes angiogenesis and osteogenesis in a co-culture system consisting of primary osteoblasts and outgrowth endothelial cells. Tissue Eng Part A 16(4): 1235-1237.
36. Drukker M, Benvenisty N. 2004; The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol 22(3): 136-141.
37. Ehrlich PJ, Lanyon LE. 2002; Mechanical strain and bone cell function: a review. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 13(9): 688-700.
38. Eriksen EF, Axelrod D, Melsen W. 1994; Bone histomorphometry. Raven Press: New York.
39. Eyre-Brook AL. 1984; The periosteum: its function reassessed. Clin Orthop Relat Res (189): 300-307.
40. Fan W, Crawford R, Xiao Y. 2010; Enhancing in vivo vascularized bone formation by cobalt chloride-treated bone marrow stromal cells in a tissue engineered periosteum model. Biomaterials 31(13): 3580-3589.
41. Fong CY, Gauthaman K, Bongso A. 2010; Teratomas from pluripotent stem cells: A clinical hurdle. J Cell Biochem 111(4): 769-781.
42. Frank O, Heim M, Jakob M et al. 2002; Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem 85(4): 737-746.
43. Fuchs S, Ghanaati S, Orth C et al. 2009a; Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Biomaterials 30(4): 526-534.
44. Fuchs S, Hofmann A, Kirkpatrick CJ. 2007; Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells. Tissue Eng 13(10): 2577-2588.
45. Fuchs S, Jiang X, Schmidt H et al. 2009b; Dynamic processes involved in the pre-vascularization of silk fibroin constructs for bone regeneration using outgrowth endothelial cells. Biomaterials 30(7): 1329-1338.
46. Fujii T, Ueno T, Kagawa T et al. 2006; Comparison of bone formation ingrafted periosteum harvested from tibia and calvaria. Microsc Res Tech 69(7): 580-584.
47. Gawlitta D, Fledderus JO, van Rijen MH et al. 2012; Hypoxia impedes vasculogenesis of in vitro engineered bone. Tissue Eng Part A 18(1-2): 208-218.
48. Gerber HP, Vu TH, Ryan AM et al. 1999; VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5(6): 623-628.
49. Germain S, Monnot C, Muller L et al. 2010; Hypoxia-driven angiogenesis: role of tip cells and extracellular matrix scaffolding. Curr Opin Hematol 17(3): 245-251.
50. Geuze RE, Wegman FF, Oner C et al. 2009; Influence of endothelial progenitor cells and platelet gel on tissue-engineered bone ectopically in goats. Tissue Eng Part A 15(11): 3669-3677.
51. Gotherstrom C, West A, Liden J et al. 2005; Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. Haematologica 90(8): 1017-1026.
52. Grellier M, Bareille R, Bourget C et al. 2009a; Responsiveness of human bone marrow stromal cells to shear stress. J Tissue Eng Regen Med 3(4): 302-309.
53. Grellier M, Granja PL, Fricain JC et al. 2009b; The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 30(19): 3271-3278.
54. Grinnemo KH, Sylven C, Hovatta O et al. 2008; Immunogenicity of human embryonic stem cells. Cell Tissue Res 331(1): 67-78.
55. Gruenloh W, Kambal A, Sondergaard C et al. 2011; Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Eng Part A 17(11-12): 1517-1525.
56. Grundel RE, Chapman MW, Yee T et al. 1991; Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. Clin Orthop Relat Res (266): 244-258.
57. Guillot PV, Gotherstrom C, Chan J et al. 2007; Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25(3): 646-654.
58. Guillotin B, Bareille R, Bourget C et al. 2008; Interaction between human umbilical vein endothelial cells and human osteoprogenitors triggers pleiotropic effect that may support osteoblastic function. Bone 42(6): 1080-1091.
59. Haynesworth SE, Goshima J, Goldberg VM et al. 1992; Characterization of cells with osteogenic potential from human marrow. Bone 13(1): 81-88.
60. Henenfeld M. 1953; The application of Davis' Law. J Natl Assoc Chirop 43(5): 23-28.
61. Henrich D, Seebach C, Kaehling C et al. 2009; Simultaneous cultivation of human endothelial-like differentiated precursor cells and human marrow stromal cells on beta-tricalcium phosphate. Tissue Eng Part C Methods 15(4): 551-560.
62. Hofmann A, Ritz U, Verrier S et al. 2008; The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds. Biomaterials 29(31): 4217-4226.
63. Holtorf HL, Jansen JA, Mikos AG. 2006; Modulation of cell differentiation in bone tissue engineering constructs cultured in a bioreactor. Adv Exp Med Biol 585: 225-241.
64. Horner EA, Kirkham J, Wood D et al. 2010; Long bone defect models for tissue engineering applications: criteria for choice. Tissue Eng Part B Rev 16(2): 263-271.
65. Hosseini A, Hogg DA. 1991a; The effects of paralysis on skeletal development in the chick embryo. I. General effects. J Anat 177: 159-168.
66. Hosseini A, Hogg DA. 1991b; The effects of paralysis on skeletal development in the chick embryo. II. Effects on histogenesis of the tibia. J Anat 177: 169-178.
67. Hudlicka O, Brown MD, May S et al. 2006; Changes in capillary shear stress in skeletal muscles exposed to long-term activity: role of nitric oxide. Microcirculation 13(3): 249-259.
68. Hutmacher DW. 2000; Scaffolds in tissue engineering bone and cartilage. Biomaterials 21(24): 2529-2543.
69. Hutmacher DW, Sittinger M. 2003; Periosteal cells in bone tissue engineering. Tissue Eng 9(Suppl 1): S45-64.
70. Illich DJ, Demir N, Stojkovic M et al. 2011; Concise review: induced pluripotent stem cells and lineage reprogramming: prospects for bone regeneration. Stem Cells 29(4): 555-563.
71. Ingram DA, Mead LE, Tanaka H et al. 2004; Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104(9): 2752-2760.
72. Ishaug SL, Crane GM, Miller MJ et al. 1997; Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 36(1): 17-28.
73. Ito H, Koefoed M, Tiyapatanaputi P et al. 2005; Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 11(3): 291-297.
74. Jackson RA, Nurcombe V, Cool SM. 2006; Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene 379: 79-91.
75. Jacobsen FS. 1997; Periosteum: its relation to pediatric fractures. J Pediatr Orthop B 6(2): 84-90.
76. Jain RK, Au P, Tam J et al. 2005; Engineering vascularized tissue. Nat Biotechnol 23(7): 821-823.
77. Jain RK, Munn LL, Fukumura D. 2002; Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer 2(4): 266-276.
78. Jones EA, le Noble F, Eichmann A. 2006; What determines blood vessel structure? Genetic prespecification vs. hemodynamics. Physiology 21: 388-395.
79. Kahle M, Wiesmann HP, Berr K et al. 2010; Embryonic stem cells induce ectopic bone formation in rats. Bio-medical materials and engineering 20(6): 371-380.
80. Kaigler D, Krebsbach PH, West ER et al. 2005; Endothelial cell modulation of bone marrow stromal cell osteogenic potential. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 19(6): 665-667.
81. Kaigler D, Wang Z, Horger K et al. 2006; VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 21(5): 735-744.
82. Kaji H, Camci-Unal G, Langer R et al. 2011; Engineering systems for the generation of patterned co-cultures for controlling cell-cell interactions. Biochim Biophys Acta 1810(3): 239-250.
83. Kalka C, Masuda H, Takahashi T et al. 2000; Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97(7): 3422-3427.
84. Kalpakcioglu BB, Morshed S, Engelke K et al. 2008; Advanced imaging of bone macrostructure and microstructure in bone fragility and fracture repair. J Bone Joint Surg Am 90(Suppl 1): 68-78.
85. Kanczler JM, Oreffo RO. 2008; Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15: 100-114.
86. Kang KT, Allen P, Bischoff J. 2011; Bioengineered human vascular networks transplanted into secondary mice reconnect with the host vasculature and re-establish perfusion. Blood 118(25): 6718-6721.
87. Kempen DH, Lu L, Heijink A et al. 2009; Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30(14): 2816-2825.
88. Ker ED, Chu B, Phillippi JA et al. 2011a; Engineering spatial control of multiple differentiation fates within a stem cell population. Biomaterials 32(13): 3413-3422.
89. Ker ED, Nain AS, Weiss LE et al. 2011b; Bioprinting of growth factors onto aligned sub-micron fibrous scaffolds for simultaneous control of cell differentiation and alignment. Biomaterials 32(32): 8097-8107.
90. Kim SS, Park MS, Cho S et al. 2010; Enhanced bone formation by marrow-derived endothelial and osteogenic cell transplantation. J Biomed Mater Res A 92(1): 246-253.
91. Kimelman-Bleich N, Seliktar D, Kallai I et al. 2011; The effect of ex vivo dynamic loading on the osteogenic differentiation of genetically engineered mesenchymal stem cell model. J Tissue Eng Regen Med 5(5): 384-393.
92. Kleinman HK, McGarvey ML, Liotta LA et al. 1982; Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21(24): 6188-6193.
93. Kneser U, Polykandriotis E, Ohnolz J et al. 2006a; Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng 12(7): 1721-1731.
94. Kneser U, Schaefer D, Polykandriotis J et al. 2006b; Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med 10(1): 7-19.
95. Knothe Tate ML, Ritzman T, Schneider F et al. 2007; Testing of a new one-stage bone-transport surgical procedure exploiting the periosteum for the repair of long-bone defects. J Bone Joint Surg Am 89(2): 307-316.
96. Ko HC, Milthorpe BK, McFarland CD. 2007; Engineering thick tissues--the vascularisation problem. Eur Cell Mater 14: 1-18; discussion 18-19.
97. Kolbe M, Xiang Z, Dohle E et al. 2011; Paracrine effects influenced by cell culture medium and consequences on microvessel-like structures in co-culture s of mesenchymal stem cells and outgrowth endothelial cells. Tissue Eng Part A 17(17-18): 2199-2212.
98. Komatsu DE, Hadjiargyrou M. 2004; Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone 34(4): 680-688.
99. Koob S, Torio-Padron N, Stark GB et al. 2011; Bone formation and neovascularization ediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects. Tissue Eng Part A 17(3-4): 311-321.
100. Kostopoulos L, Karring T. 1995; Role of periosteum in the formation of jaw bone. An experiment in the rat. J Clin Periodontol 22(3): 247-254.
101. Kruyt MC, Dhert WJ, Yuan H et al. 2004; Bone tissue engineering in a critical size defect compared to ectopic implantations in the goat. J Orthop Res: 22(3): 544-551.
102. Kumar S, Wan C, Ramaswamy G et al. 2010; Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther 18(5): 1026-1034.
103. Kuznetsov SA, Cherman N, Robey PG. 2011; In vivo bone formation by progeny of human embryonic stem cells. Stem Cells Dev 20(2): 269-287.
104. Langer R, Vacanti JP. 1993. Tissue engineering. Science 260(5110): 920-926.
105. Lanza RP, Langer RS, Vacanti J. 2007; Principles of tissue engineering 3rd edn. Elsevier / Academic Press: Amsterdam; Boston.
106. Le Blanc K. 2003; Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5(6): 485-489.
107. Lee DY, Cho TJ, Kim JA et al. 2008; Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis. Bone 42(5): 932-941.
108. Lee KE, Silva A, Mooney DJ. 2011; Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 8(55): 153-170.
109. Lelkes G. 1958; Experiments in vitro on the role of movement in the development of joints. J Embryol Exp Morphol 6(2): 183-186.
110. Lemperle SM, Calhoun CJ, Curran RW et al. 1998; Bony healing of large cranial and mandibular defects protected from soft-tissue interposition: A comparative study of spontaneous bone regeneration, osteoconduction, and cancellous autografting in dogs. Plast Reconstr Surg 101(3): 660-672.
111. Leondes CT. 2001; Biomechanical systems: techniques and applications. 4 vols. CRC Press: Boca Raton.
112. Lin K, Hsu PP, Chen BP et al. 2000; Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc Natl Acad Sci USA 97(17): 9385-9389.
113. Liu Y, Teoh SH, Chong M et al. 2012; Vvasculogenic and osteogenesis-enhancing potential of human umbilical cord blood endothelial colony-forming cells stem cells. In press.
114. Lovett M, Lee K, Edwards A et al. 2009; Vascularization strategies for tissue engineering. Tissue Eng Part B Rev 15(3): 353-370.
115. Marie P, Debiais F, Cohen-Solal M et al. 2000; New factors controlling bone remodeling. Joint, bone, spine: revue du rhumatisme 67(3): 150-156.
116. Masuda H, Alev C, Akimaru H et al. 2011; Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. Circ Res 109(1): 20-37.
117. Matsumoto T, Kawamoto A, Kuroda R et al. 2006; Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol 169(4): 1440-1457.
118. Matsumoto T, Mifune Y, Kawamoto A et al. 2008; Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing. J Cell Physiol 215(1): 234-242.
119. McBride SH, Knothe U, Brianza S et al. 2010; Periosteal mechanics from the macro to nano scales. In: Proceedings of the United States National Applied and Theoretical Mechanics Conference, Pittsburgh.
120. McCloskey KE, Smith DA, Jo H et al. 2006; Embryonic stem cell-derived endothelial cells may lack complete functional maturation in vitro. J Vasc Res 43(5): 411-421.
121. McCoy RJ, O'Brien FJ. 2010; Influence of shear stress in perfusion bioreactor cultures for the development of three-dimensional bone tissue constructs: a review. Tissue Eng Part B Rev 16(6): 587-601.
122. Meinel L, Betz O, Fajardo R et al. 2006; Silk based biomaterials to heal critical sized femur defects. Bone 39(4): 922-931.
123. Meinel L, Fajardo R, Hofmann S et al. 2005; Silk implants for the healing of critical size bone defects. Bone 37(5): 688-698.
124. Melcher AH, Accursi GE. 1971; Osteogenic capacity of periosteal and osteoperiosteal flaps elevated from the parietal bone of the rat. Arch Oral Biol 16(6): 573-580.
125. Melero-Martin JM, De Obaldia ME, Kang SY et al. 2008; Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103(2): 194-202.
126. Menger MD, Lehr HA. 1993; Scope and perspectives of intravital microscopy--bridge over from in vitro to in vivo. Immunol Today 14(11): 519-522.
127. Mifune Y, Matsumoto T, Kawamoto A et al. 2008; Local delivery of granulocyte colony stimulating factor-mobilized cd34-positive progenitor cells using bioscaffold for modality of unhealing bone fracture. Stem Cells 26(6): 1395-405.
128. Mironov V, Kasyanov V, Markwald RR. 2011; Organ printing: from bioprinter to organ biofabrication line. Curr Opin Biotechnol 22(5): 667-673.
129. Moioli EK, Clark PA, Chen M et al. 2008; Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One 3(12): e3922.
130. Moon S, Hasan SK, Song Y et al. 2010; Layer by layer three-dimensional tissue epitaxy by cell-laden hydrogel droplets. Tissue Eng Part C Methods 16(1): 157-166.
131. Murohara T. 2010; Cord blood-derived early outgrowth endothelial progenitor cells. Microvasc Res 79(3): 174-177.
132. Muschler GF, Nakamoto C, Griffith LG. 2004; Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86-A(7): 1541-1558.
133. Muschler GF, Raut VP, Patterson TE et al. 2010; The design and use of animal models for translational research in bone tissue engineering and regenerative medicine. Tissue Eng Part B Rev 16(1): 123-145.
134. Nowlan NC, Prendergast PJ, Murphy P. 2008; Identification of mechanosensitive genes during embryonic bone formation. PLoS Comput Biol 4(12): e1000250.
135. O'Loughlin PF, Morr S, Bogunovic L et al. 2008; Selection and development of preclinical models in fracture-healing research. The Journal of bone and joint surgery. American volume 90(Suppl 1): 79-84.
136. Ouyang HW, Cao T, Zou XH et al. 2006; Mesenchymal stem cell sheets revitalize nonviable dense grafts: implications for repair of large-bone and tendon defects. Transplantation 82(2): 170-174.
137. Ozaki A, Tsunoda M, Kinoshita S et al. 2000; Role of fracture hematoma and periosteum during fracture healing in rats: interaction of fracture hematoma and the periosteum in the initial step of the healing process. Journal of orthopaedic science: official journal of the Japanese Orthopaedic Association 5(1): 64-70.
138. Panjabi MM, Lindsey RW, Walter SD et al. 1989; The clinician's ability to evaluate the strength of healing fractures from plain radiographs. J Orthop Trauma 3(1): 29-32.
139. Peng H, Wright V, Usas A et al. 2002; Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110(6): 751-759.
140. Pittenger MF, Mackay AM, Beck S et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284(5411): 143-147.
141. Prockop DJ. 1997; Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276(5309): 71-74.
142. Qi H, Aguiar DJ, Williams SM et al. 2003; Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc Natl Acad Sci USA 100(6): 3305-3310.
143. Quarto R, Mastrogiacomo M, Cancedda R et al. 2001; Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344(5): 385-386.
144. Reichert JC, Saifzadeh S, Wullschleger ME et al. 2009; The challenge of establishing preclinical models for segmental bone defect research. Biomaterials 30(12): 2149-2163.
145. Rho JY, Kuhn-Spearing L, Zioupos P. 1998; Mechanical properties and the hierarchical structure of bone. Med Eng Phys 20(2): 92-102.
146. Robey PG. 2011; Cell sources for bone regeneration: the good, the bad, and the ugly (but promising). Tissue Eng Part B Rev 17(6): 423-430.
147. Rouwkema J, de BoeJ R, Van Blitterswijk CA. 2006; Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng 12(9): 2685-2693.
148. Rouwkema J, Rivron NC, van Blitterswijk CA. 2008; Vascularization in tissue engineering. Trends Biotechnol 26(8): 434-441.
149. Rouwkema J, Westerweel P, de Boer E et al. 2009; The use of endothelial progenitor cells for prevascularized bone tissue engineering. Tissue Eng Part A 15(8): 2015-2027.
150. Rozen N, Bick T, Bajayo A et al. 2009; Transplanted blood-derived endothelial progenitor cells (EPC) enhance bridging of sheep tibia critical size defects. Bone 45(5): 918-924.
151. Runyan CM, Jones DC, Bove KE et al. 2010; Porcine allograft mandible revitalization using autologous adipose-derived stem cells, bone morphogenetic protein-2, and periosteum. Plast Reconstr Surg 125(5): 1372-1382.
152. Salgado AJ, Coutinho OP, Reis RL. 2004; Bone tissue engineering: state of the art and future trends. Macromol Biosci 4(8): 743-765.
153. Salter EK, Goh BC, Hung BP et al. 2011; Bone tissue engineering bioreactors - a role in the clinic? Tissue Eng. Part B Rev 18(1): 62-75.
154. Satoh T, Tsuchiya M, Harii K. 1983; A vascularised iliac musculo-periosteal free flap transfer: a case report. Brit J Plast Surg 36(1): 109-112.
155. Schantz JT, Woodruff MA, Lam CX et al. 2012; Differentiation potential of mesenchymal; progenitor cells following transplantation into calvarial defects. J Mech Behav Biomed Mater 11: 132-142.
156. Schuurman W, Khristov V, Pot M et al. 2011; Bioprinting of hybrid tissue constructs with tailorable mechanical properties. Biofabrication 3(2): 021001.
157. Seebach C, Henrich D, Kahling C et al. 2010; Endothelial progenitor cells and mesenchymal stem cells seeded onto beta-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats. Tissue Eng Part A 16(6): 1961-1970.
158. Shields LB, Raque GH, Glassman SD et al. 2006; Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31(5): 542-547.
159. Shimizu T, Sasano Y, Nakajo S et al. 2001; Osteoblastic differentiation of periosteum-derived cells is promoted by the physical contact with the bone matrix in vivo. Anat Rec 264(1): 72-81.
160. Sierra DH. 1993; Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J Biomater Appl 7: 309.
161. Sikavitsas VI, Bancroft GN, Holtorf HL et al. 2003; Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci USA 100(25): 14683-14688.
162. Simons M, Annex BH, Laham RJ et al. 2002; Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105(7): 788-793.
163. Simpson AH. 1985; The blood supply of the periosteum. J Anat 140(Pt 4): 697-704.
164. Skoog, T. 1965; The use of periosteal flaps in the repair of clefts of the primary palate. Uppsalla, Sweden. Cleft Palate J 2: 332-339
165. Soltan M, Smiler D, Soltan C. 2009; The inverted periosteal flap: a source of stem cells enhancing bone regeneration. Implant Dent 18(5): 373-379.
166. Song HH, Shi W, Xiang YY et al. 2005; The loss of glypican-3 induces alterations in Wnt signaling. J Biol Chem 280(3): 2116-2125.
167. Song JW, Munn LL. 2011; Fluid forces control endothelial sprouting. Proc Natl Acad Sci USA 108(37): 15342-15347.
168. Stevenson S. 1999; Biology of bone grafts. Orthop Clin North Am 30(4): 543-552.
169. Stolberg S, McCloskey KE. 2009; Can shear stress direct stem cell fate? Biotechnol Prog 25(1): 10-19.
170. Street J, Bao M, deGuzman L et al. 2002; Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99(15): 9656-9661.
171. Szpalski C, Barbaro M, Sagebin F et al. 2012; Bone tissue engineering: current strategies and techniques-part II: cell types. Tissue Eng Part B Rev 18(4): 258-269.
172. Tateishi-Yuyama E, Matsubara H, Murohara T et al. 2002; Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360(9331): 427-435.
173. Tortelli F, Pujic N, Liu Y et al. 2009; Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone. Tissue Eng Part A 15(9): 2373-2383.
174. Tran Van PT, Vignery A, Baron R. 1982; Cellular kinetics of the bone remodeling sequence in the rat. Anat Rec 202(4): 445-451.
175. Trueta J, Buhr AJ. 1963; The vascular contribution to osteogenesis. V. The vasculature supplying the epiphysial cartilage in rachitic rats. J Bone Joint Surg Br 45: 572-581.
176. Tsigkou O, Pomerantseva I, Spencer JA et al. 2010; Engineered vascularized bone grafts. Proc Natl Acad Sci USA 107(8): 3311-3316.
177. Tzima E, Irani-Tehrani M, Kiosses WB et al. 2005; A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437(7057): 426-431.
178. Unger RE, Ghanaati S, Orth C et al. 2010; The rapid anastomosis between prevascularized networks on silk fibroin scaffolds generated in vitro with co-culture s of human microvascular endothelial and osteoblast cells and the host vasculature. Biomaterials 31(27): 6959-6967.
179. Unger RE, Sartoris A, Peters K et al. 2007; Tissue-like self-assembly in co-cultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials. Biomaterials 28(27): 3965-3976.
180. Usami K, Mizuno H, Okada K et al. 2009; Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation. J Biomed Mater Res A 90(3): 730-741.
181. Utvag SE, Grundnes O, Reikeraos O. 1996; Effects of periosteal stripping on healing of segmental fractures in rats. J Orthop Trauma 10(4): 279-284.
182. Villars F, Bordenave L, Bareille R et al. 2000; Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF? J Cell Biochem 79(4): 672-685.
183. Villars F, Guillotin B, Amedee T et al. 2002; Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol 282(4): C775-785.
184. Wan C, Gilbert SR, Wang Y et al. 2008; Role of hypoxia inducible factor-1 alpha pathway in bone regeneration. J Musculoskelet Neuronal Interact 8(4): 323-324.
185. Wan C, Shao J, Gilbert SR et al. 2010; Role of HIF-1alpha in skeletal development. Ann N Y Acad Sci 1192: 322-326.
186. Wang Y, Wan C, Deng L et al. 2007; The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117(6): 1616-1626.
187. Warnke PH, Springer IN, Wiltfang J et al. 2004; Growth and transplantation of a custom vascularised bone graft in a man. Lancet 364(9436): 766-770.
188. Weng D, Hurzeler MB, Quinones CR et al. 2000; Contribution of the periosteum to bone formation in guided bone regeneration. A study in monkeys. Clin Oral Implants Res 11(6): 546-554.
189. Werntz JR, Lane JM, Burstein AH et al. 1996; Qualitative and quantitative analysis of orthotopic bone regeneration by marrow. Journal of orthopaedic research: official publication of the Orthopaedic Research Society 14(1): 85-93.
190. Wolff J. 1892; Das Gezetz der Transformation der Knochen. Hirschwald: Berlin.
191. Wong DA, Kumar A, Jatana S et al. 2008; Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). The spine journal: official journal of the North American Spine Society 8(6): 1011-1018.
192. Wood LK, Asada R. 2011; Stochastic modeling and identification of emergent behaviors of an Endothelial Cell population in angiogenic pattern formation. The International Journal of Robotics Research 30(6): 659-677.
193. Wu DC, Boyd AS, Wood KJ. 2008; Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells 26(8): 1939-1950.
194. Xue Y, Xing Z, Hellem S et al. 2009; Endothelial cells influence the osteogenic potential of bone marrow stromal cells. Biomed Eng Online 8: 34.
195. Yamamoto K, Sokabe T, Watabe T et al. 2005; Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro. Am J Physiol Heart Circ Physiol 288(4): H1915-1924.
196. Yamamoto K, Takahashi T, Asahara T et al. 2003; Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J Appl Physiol 95(5): 2081-2088.
197. Yoder MC, Mead LE, Prater D et al. 2007; Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109(5): 1801-1809.
198. Zelzer E, McLean W, Ng Y et al. 2002; Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129(8): 1893-1904.
199. Zhang ZY, Teoh SH, Chong MS et al. 2010a; Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects. Biomaterials 31(4): 608-620.
200. Zhang ZY, Teoh SH, Chong MS et al. 2009a; Superior osteogenic capacity for bone tissue engineering of fetal compared to perinatal and adult mesenchymal stem cells. Stem Cells 27(1): 126-137.
201. Zhang ZY, Teoh SH, Chong WS et al. 2009b; A biaxial rotating bioreactor for the culture of fetal mesenchymal stem cells for bone tissue engineering. Biomaterials 30(14): 2694-2704.
202. Zhang ZY, Teoh SH, Hui JH et al. 2012; The potential of human fetal mesenchymal stem cells for off-the-shelf bone tissue engineering application. Biomaterials 33(9): 2656-2672.
203. Zhang ZY, Teoh SH, Teo EY et al. 2010b; A comparison of bioreactors for culture of fetal mesenchymal stem cells for bone tissue engineering. Biomaterials 31(33): 8684-8695. Epub 2010 Aug 24.
204. Zhao T, Zhang ZN, Rong Z et al. 2011; Immunogenicity of induced pluripotent stem cells. Nature 474(7350): 212-215.
205. Zou D, Zhang Z, Ye D et al. 2011; Repair of critical-sized rat calvarial defects using genetically engineered bone marrow-derived mesenchymal stem cells overexpressing hypoxia-inducible factor-1alpha. Stem Cells 29(9): 1380-1390.